Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2019
Pharma News, 2019
Cholera kills two, infects 1,400 in cyclone-hit Mozambique
A cyclone-induced cholera outbreak in central Mozambique has killed two people and infected more than 1,400, the government announced Tuesday on the eve of the launch of a mass vaccination drive.
Vitamins, carotenoids associated with lower risk for cataract
(HealthDay)—Higher consumption of certain vitamins and carotenoids is associated with a significantly decreased risk for age-related cataract (ARC) in cohort studies, according to a ...
Depression, obesity, chronic pain could be treated by targeting the same key protein
Major depression, obesity, and chronic pain are all linked to the effects of one protein, called “FK506-binding protein 51,” or FKBP51.
Next-generation single-dose antidotes for opioid overdoses
The U.
Party drug linked to new treatment for sleep disorder
A new innovative approach is being tested to treat people with a severe sleep disorder called narcolepsy.
Gilteritinib improves survival for patients with acute myeloid leukemia
Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for patients with relapsed or refractory acute myeloid leukemia (AML) harboring a FLT3 mutation co...
The state of New York accuses six pharmaceutical companies in the fraudulent marketing of opioid analgesics
The New York Attorney General is suing OxyContin maker Purdue Pharma, Johnson & Johnson, McKesson Corp.
3D printed tissues may keep athletes in action
HOUSTON - (March 28, 2019) - Bioscientists are moving closer to 3D-printed artificial tissues to help heal bone and cartilage typically damaged in sports-related injuries to knees, ankles and ...
AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal
(Reuters) - AstraZeneca Plc will pay up to $6.
First gene therapy to treat rare blood disease nears European approval
The first gene therapy to treat a rare blood disorder is one step closer to approval Friday following a recommendation by European officials.
FDA approves treatment for patients with a type of inflammatory arthritis
SILVER SPRING, Md.
Number of prescription rises but cost falls again
Latest data from NHS Digital shows an increase in the number of prescription items dispensed in the community, but a drop in their cost to the NHS.
41
42
43
44
45
46
47
48
49
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds